Gilbert Syndrome/ Irinotecan Toxicity assessment (UGTIAI Genotyping)
← Molecular Biology Gilbert Syndrome/ Irinotecan Toxicity assessment (UGTIAI Genotyping)

Gilbert Syndrome/ Irinotecan Toxicity assessment (UGTIAI Genotyping)

৳ 15,000.00

Gilbert Syndrome / Irinotecan Toxicity Assessment (UGT1A1 Genotyping)

UGT1A1 Genotyping is a genetic test used to identify variations in the UGT1A1 gene associated with Gilbert syndrome and an increased risk of irinotecan-related toxicity. It helps assess an individual's ability to metabolize certain medications and supports personalized treatment planning, particularly for patients receiving irinotecan chemotherapy.